Powered by

Medicare copays for new Alzheimer's drug could reach $11,500

Jun 11, 2021 - St. Paul Pioneer Press (Minnesota)

WASHINGTON (AP) - A new $56,000-a-year Alzheimer's drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

By RICARDO ALONSO-ZALDIVAR and MATTHEW PERRONE

WASHINGTON (AP) - A new $56,000-a-year Alzheimer's drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually...